Literature DB >> 32841517

Posterior-chamber phakic implantable collamer lenses with a central port: a review.

Robert Montés-Micó1,2, Ramón Ruiz-Mesa1, José Luís Rodríguez-Prats1, Pedro Tañá-Rivero1.   

Abstract

We aimed to summarize the outcomes reported following the implantation of the V4c implantable collamer lens with a central port (ICL, STAAR Surgical Inc) for myopia correction. A literature search in PubMed, Web of Science and Scopus was carried out to identify publications reporting clinical outcomes of patients who were implanted with the V4c ICL model and had a follow-up period of at least 6 months. A total of 35 clinical studies published between 2012 and 2020 were included in the present review. A comprehensive analysis of the available data was performed, focusing on visual and refractive outcomes at different time-points post-surgery. In addition, adverse events and other parameters such as endothelial cell density, intraocular pressure and vault measurements-which were evaluated in some of the studies-were also compared. This review encompassed a total of 2904 eyes. The outcomes reported in this review lead us to conclude that ICL V4c implantation for myopia correction is a safe and efficient procedure, with stable visual and refractive outcomes and low adverse event rates. The patient's anterior segment should be thoroughly characterized, and the ICL parameters should be carefully selected so as to achieve good outcomes and avoid complications.
© 2020 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.

Entities:  

Keywords:  adverse events; implantable collamer lens; intraocular pressure; myopia; phakic; refraction; vault; visual acuity

Year:  2020        PMID: 32841517     DOI: 10.1111/aos.14599

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  8 in total

1.  Assessment of biosafety and implantation feasibility of novel phakic refractive lens.

Authors:  Shaohua Zhang; Chang Huang; Huamao Miao; Junyao Wu; Chao Xing; Zhaoxing Dai; Jianguo Sun
Journal:  Int Ophthalmol       Date:  2022-05-13       Impact factor: 2.029

2.  Changes in Accommodative and Binocular Function following Phakic Intraocular Lens for High and Low-to-Moderate Myopia.

Authors:  Esther López-Artero; Francisco Poyales; Nuria Garzón; Alicia Matamoros; Alba Sáez; Ying Zhou; María García-Montero
Journal:  Int J Environ Res Public Health       Date:  2022-05-31       Impact factor: 4.614

Review 3.  In vivo optical quality of posterior-chamber phakic implantable collamer lenses with a central port.

Authors:  Robert Montés-Micó; Francisco Pastor-Pascual; Enrique Artiaga-Elordi; Ramón Ruiz-Mesa; Pedro Tañá-Rivero
Journal:  Eye Vis (Lond)       Date:  2021-08-16

4.  Visual function assessment of posterior-chamber phakic implantable collamer lenses with a central port.

Authors:  Zongxia Bai; Danyao Nie; Jing Zhang; Huiling Hu; Liangnan Sun; Kun Zeng; Jiantao Wang; Xinhua Liu
Journal:  Ann Transl Med       Date:  2022-02

5.  Agreement of implantable collamer lens sizes using parameters from different devices.

Authors:  Manachai Nonpassopon; Passara Jongkhajornpong; Prae Phimpho; Nontawat Cheewaruangroj; Kaevalin Lekhanont; Varintorn Chuckpaiwong
Journal:  BMJ Open Ophthalmol       Date:  2022-03-08

6.  Low Diopter Phakic Implantable Collamer Lens: Refractive and Visual Outcomes in Low Myopia and Myopic Astigmatism.

Authors:  Ernesto Alonso-Juárez; Daniel Velázquez-Villoria
Journal:  Clin Ophthalmol       Date:  2022-09-02

7.  Three-year follow-up of posterior chamber phakic intraocular lens with a central port design after deep anterior lamellar keratoplasty.

Authors:  Belén Alfonso-Bartolozzi; Carlos Lisa; Luis Fernández-Vega-Cueto; Begoña Baamonde; David Madrid-Costa; José F Alfonso
Journal:  Eye Vis (Lond)       Date:  2022-09-07

8.  Clinical observations of EVO-ICL implantation and changes in corneal astigmatism using a modified technique.

Authors:  Ying Wang; Ruibo Yang; Yue Huang; Chen Zhang; Hui Liu; Zhe Jia; Shaozhen Zhao
Journal:  BMC Ophthalmol       Date:  2022-09-23       Impact factor: 2.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.